Literature DB >> 15355424

Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?

L Ide, I Buysschaert, H Demuynck, R De Man, A Verlinde, E De Laere, I Surmont.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15355424     DOI： 10.1111/j.1469-0691.2004.00945.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  5 in total

1.  Prophylaxis with Isavuconazole or Posaconazole Protects Immunosuppressed Mice from Pulmonary Mucormycosis.

Authors:  Teclegiorgis Gebremariam; Sondus Alkhazraji; Clara Baldin; Laura Kovanda; Nathan P Wiederhold; Ashraf S Ibrahim
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 2.  Novel perspectives on mucormycosis: pathophysiology, presentation, and management.

Authors:  Brad Spellberg; John Edwards; Ashraf Ibrahim
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

3.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

Review 4.  Recent advances in the management of mucormycosis: from bench to bedside.

Authors:  Brad Spellberg; Thomas J Walsh; Dimitrios P Kontoyiannis; John Edwards; Ashraf S Ibrahim
Journal:  Clin Infect Dis       Date:  2009-06-15       Impact factor: 9.079

5.  The successful use of amphotericin B followed by oral posaconazole in a rare case of invasive fungal sinusitis caused by co-infection with mucormycosis and aspergillus.

Authors:  Sharana Mahomed; Sujith Basanth; Koleka Mlisana
Journal:  IDCases       Date:  2015-10-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.